Related references
Note: Only part of the references are listed.Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta-Analysis
Feng Zhou et al.
HEPATOLOGY (2019)
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis
Jie Li et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
LXRα Promotes Hepatosteatosis in Part Through Activation of MicroRNA-378 Transcription and Inhibition of Ppargc1β Expression
Tianpeng Zhang et al.
HEPATOLOGY (2019)
Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China)
Jian Gao Fan et al.
JOURNAL OF DIGESTIVE DISEASES (2019)
miRBase: from microRNA sequences to function
Ana Kozomara et al.
NUCLEIC ACIDS RESEARCH (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis
Qiaozhu Su et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Regulation and functions of MicroRNA-149 in human cancers
Yingru Zhi et al.
CELL PROLIFERATION (2018)
Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis
Alessandro Mantovani et al.
DIABETES CARE (2018)
FGF21 gene therapy as treatment for obesity and insulin resistance
Veronica Jimenez et al.
EMBO MOLECULAR MEDICINE (2018)
Deficiency of fibroblast growth factor 21 (FGF21) promotes hepatocellular carcinoma (HCC) in mice on a long term obesogenic diet
Garima Singhal et al.
MOLECULAR METABOLISM (2018)
Fatty liver and FGF21 physiology
Eleftheria Maratos-Flier
EXPERIMENTAL CELL RESEARCH (2017)
MicroRNA-27a regulates hepatic lipid metabolism and alleviates NAFLD via repressing FAS and SCD1
Meiyuan Zhang et al.
SCIENTIFIC REPORTS (2017)
MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1
Guo-yi Wu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21
Junjie Xiao et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism
Xingyong Wan et al.
JOURNAL OF HEPATOLOGY (2016)
Fasting induces a subcutaneous-to-visceral fat switch mediated by microRNA-149-3p and suppression of PRDM16
Hanying Ding et al.
NATURE COMMUNICATIONS (2016)
Fibroblast growth factor 21 reflects liver fat accumulation and dysregulation of signalling pathways in the liver of C57BL/6J mice
Fenni Rusli et al.
SCIENTIFIC REPORTS (2016)
Association of the serum uric acid level with liver histology in biopsy-proven non-alcoholic fatty liver disease
Qian Huang et al.
BIOMEDICAL REPORTS (2016)
High Concentrations of Uric Acid Inhibit Angiogenesis via Regulation of the Kruppel-Like Factor 2-Vascular Endothelial Growth Factor-A Axis by miR-92a
Shandong Yu et al.
CIRCULATION JOURNAL (2015)
Lowering Uric Acid With Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic Hyperuricemia
Mumtaz Takir et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2015)
Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease
Jiexia Ding et al.
SCIENTIFIC REPORTS (2015)
Fibroblast Growth Factor 21 Protects Against Acetaminophen-Induced Hepatotoxicity by Potentiating Peroxisome Proliferator-Activated Receptor Coactivator Protein-1α-Mediated Antioxidant Capacity in Mice
Dewei Ye et al.
HEPATOLOGY (2014)
Hydrodynamic delivery of FGF21 gene alleviates obesity and fatty liver in mice fed a high-fat diet
Mingming Gao et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes
Yea-Jin Choi et al.
LABORATORY INVESTIGATION (2014)
Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway
Yanqiong Zhang et al.
MOLECULAR CANCER (2014)
Prevalence and Risk Factors for the Development of Nonalcoholic Fatty Liver Disease in a Nonobese Chinese Population: the Zhejiang Zhenhai Study
Chengfu Xu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: A 3-year prospective study in China
Huating Li et al.
JOURNAL OF HEPATOLOGY (2013)
Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey
Jeffrey C. Sirota et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
Uric Acid Induces Hepatic Steatosis by Generation of Mitochondrial Oxidative Stress POTENTIAL ROLE IN FRUCTOSE-DEPENDENT AND -INDEPENDENT FATTY LIVER
Miguel A. Lanaspa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis
Wei-Chih Tsai et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease
S. Petta et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma
Lei Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease
M. Estep et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Hypouricemic Therapy: A Novel Potential Therapeutic Option for Nonalcoholic Fatty Liver Disease
Cheng-Fu Xu et al.
HEPATOLOGY (2010)
Association Between Serum Uric Acid Level and Chronic Liver Disease in the United States
Anita Afzali et al.
HEPATOLOGY (2010)
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Giovanni Targher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
High Serum Uric Acid Increases the Risk for Nonalcoholic Fatty Liver Disease: A Prospective Observational Study
Chengfu Xu et al.
PLOS ONE (2010)
Role of MicroRNA-155 at Early Stages of Hepatocarcinogenesis Induced by Choline-Deficient and Amino Acid-Defined Diet in C57BL/6 Mice
Bo Wang et al.
HEPATOLOGY (2009)
Association of serum uric acid level with non-alcoholic fatty liver disease: A cross-sectional study
Youming Li et al.
JOURNAL OF HEPATOLOGY (2009)
Differential expression of microRNAs in mouse liver under aberrant energy metabolic status
Shengjie Li et al.
JOURNAL OF LIPID RESEARCH (2009)
MicroRNAs - Critical regulators of development, cellular physiology and malignancy
JT Mendell
CELL CYCLE (2005)
Share Paper
